Navigating the life science ecosystem
Have you considered what support and opportunities are available to you as a company or entrepreneur working in life sciences? Although there are many opportunities, they can be difficult to find. No longer. There is now a visualisation tool of the life science ecosystem in southern Stockholm.
Flemingsberg Science is responsible for the visualisation, which has been produced within the framework of the Stockholm Life Tech project. The interactive image is based on an overview of everything from innovation support and current actors to research infrastructures and life science companies.
“The aim of the overview and the visualisation is to improve support to all those who need help to make their way through the extensive life science ecosystem. The tools make it easier to find what you’re looking for and to get a better, broader picture of the entire ecosystem,” says Johnny Högberg, CEO Flemingsberg Science.
The visualisation shows the geographical proximity between various actors and entities in Flemingsberg. Testbeds, academic institutions and regional actors are included. There is also a section that shows the area’s specialisations with connections to businesses and support functions.
Click here for the Life Science Ecosystem of Southern Stockholm visualisation.
If you would like to add to the visualisation in any way, please contact: Pernilla Boström at pernilla.bostrom@flemingsbergscience.se.
Chris Heister: “Everyone who has made this journey feels as though they’re fighting the system a bit.”
Even if Chris Heister shifts down a gear when she leaves her role as council leader in Stockholm, she is unlikely be drawing on her pension any time soon. The class journey she has made from growing up in a countryside idyll, north of Stockholm, has given her a momentum that continually drives her forward.
Evren Alici set to make cancer a liveable illness
A recent study could pave the way to treating a type of bone marrow cancer. The aim is to transform the cancer from being incurable to a disease that it is possible to live with. The research behind the study was conducted in Evren Alici’s group at Campus Flemingsberg.
Karin Mellström: “Co-operation is the key to success”
After 10 years as a start-up, CellProtect Nordic Pharmaceuticals has taken a major step forward. Our patient and careful work is now bearing fruit, explains Karin Mellström, CEO and founder. Looking back on her career, she sums it up by saying: “I’d never been bored for a second!”
Matti Sällberg: “Vital to contribute facts to the debate”
During the course of the pandemic, he has appeared on an almost daily basis in the morning papers or on the TV news. Matti Sällberg fast became an expert the media called for help explaining everything from vaccine development to the spread of infection.
